Navigation Links
The flip side of AIDS cocktails – HAART regime damages live

HIV infected patients on highly active antiretroviral therapy (HAART regime) are forced to stop the treatment because of the toxic side effects of the treatment, which causes liver damage. According to a study led by Dr. Raymond T. Chung, who presented the findings at Digestive Disease Week in Atlanta last week, severe liver toxicity forced almost one in every four patients to stop the treatment.

Regimens that contained drugs called nonnucleoside reverse transcriptase inhibitors, especially nevirapine and efavirenz, were particularly hard on the liver, Chung and colleagues found. In more than 25% of the cases the HAART regime cost elevation of liver enzymes to more than five times the upper limit of normal resulting in severe liver toxicity.

The drug cocktails have however clearly improved the condition of the patient in terms of controlling the HIV disease but the side effects on liver forced many to stop treatment. Dr. Chung said the next step would be to see if there are factors that may help doctors predict which HIV infected patients are most at risk for severe liver toxicity with HAART. The idea would be to single out those patients who require close monitoring.


'"/>




Page: 1

Related medicine news :

1. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
2. Combination regime may work against prostate cancer
3. Hormone regimen and how recently used may determine cancer risk
4. Cardiac events better treated with intense cholesterol-lowering regime
5. Simplest therapeutic regimen found less effective against HIV
6. Protective regimen for acute Graft-versus-host disease
7. Diet & Exercise regime Not Harmful For Overweight, Lactating Mothers Or their Infants
8. Food packaging with Bisphenol A damages the brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... of the GlycoMark test throughout the Northeast U.S. , GlycoMark is the ... diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: